Lin D, Zhang L H, Chiao E, Miller W L
Department of Pediatrics, University of California San Francisco 94143-0978.
Mol Endocrinol. 1994 Mar;8(3):392-402. doi: 10.1210/mend.8.3.8015556.
Cytochrome P450c17 is the single enzyme having steroid 17 alpha-hydroxylase and 17,20 lyase activities. We sought to model the active site of this enzyme to identify residues contributing to its catalytic activities, and to test the roles of the identified amino acids by altering them via site-directed mutagenesis. Using the MIDAS-plus program, we modeled P450c17 and the structurally related steroid 21-hydroxylase, P450c21, on the crystallographically determined structure of bacterial P450cam. By positioning the progesterone substrate into each model, we identified five residues that appeared crucial for determining whether progesterone would undergo 17 alpha-hydroxylation (by P450c17) or 21-hydroxylation (by P450c21). Each identified residue in the P450c17 sequence was changed to the corresponding residue in the P450c21 sequence, yielding the four P450c17 mutants L102Y, G111D, G301l, and M369L + l371L. The mutants were transfected into COS-1 cells and their 17 alpha-hydroxylase, 17,20 lyase, and 21-hydroxylase activities were assayed by incubation with [14C]pregnenolone, [3H]17OH-pregnenolone, and [3H]17OH-progesterone and TLC. The L102Y and M369L + l371L mutants retained 50-80% of 17 alpha-hydroxylase and 70-100% of 17,20 lyase activity, while the G111D and G301l mutants lost both activities, but no mutants acquired detectable 21-hydroxylase activity (0.1% of wild type P450c21). Combination of the two mutants that retained partial activity (L102Y and M369L + l371L) yielded a single protein that retained 40% of 17 alpha-hydroxylase and 50% of 17,20 lyase activity, but none of the seven possible vectors expressing two, three, or all four of the mutations in a single enzyme yielded detectable 21-hydroxylase activity. The mutations D298V and D298S were predicted to ablate 17,20 lyase activity while retaining 17 alpha-hydroxylase activity, but were both inactive. These studies indicate that models based on the crystal structure of P450cam correctly predict many gross architectural features of steroidogenic enzymes and that many of the predicted residues are in or near the active site of P450c17. However, because enzymatic activity requires interactions between the enzyme and substrate at distances of less than 1 A, and modeling cannot predict atomic loci to greater than 1.5-2.0 A, it was not possible to design mutants that would confer 21-hydroxylase activity to P450c17. Currently available data cannot predict the structural and amino acid sequence requirements for a specific P450 activity.
细胞色素P450c17是唯一具有类固醇17α-羟化酶和17,20裂解酶活性的酶。我们试图对该酶的活性位点进行建模,以确定对其催化活性有贡献的残基,并通过定点诱变改变这些氨基酸来测试所鉴定氨基酸的作用。使用MIDAS-plus程序,我们基于细菌P450cam的晶体结构对P450c17和结构相关的类固醇21-羟化酶P450c21进行建模。通过将孕酮底物置于每个模型中,我们确定了五个残基,这些残基对于确定孕酮是进行17α-羟化(由P450c17催化)还是21-羟化(由P450c21催化)似乎至关重要。P450c17序列中每个鉴定出的残基都被替换为P450c21序列中的相应残基,从而产生了四个P450c17突变体L102Y、G111D、G301l和M369L + l371L。将这些突变体转染到COS-1细胞中,并通过与[14C]孕烯醇酮、[3H]17OH-孕烯醇酮和[3H]17OH-孕酮孵育以及薄层层析法来测定它们的17α-羟化酶、17,20裂解酶和21-羟化酶活性。L102Y和M369L + l371L突变体保留了50 - 80%的17α-羟化酶活性和70 - 100%的17,20裂解酶活性,而G111D和G301l突变体则失去了这两种活性,但没有突变体获得可检测到的21-羟化酶活性(为野生型P450c21的0.1%)。保留部分活性的两个突变体(L102Y和M369L + l371L)组合产生了一种单一蛋白质,该蛋白质保留了40%的17α-羟化酶活性和50%的17,20裂解酶活性,但在单一酶中表达两个、三个或所有四个突变的七个可能载体中,没有一个产生可检测到的21-羟化酶活性。预测突变D298V和D298S会消除17,20裂解酶活性,同时保留17α-羟化酶活性,但两者均无活性。这些研究表明,基于P450cam晶体结构的模型正确地预测了类固醇生成酶的许多总体结构特征,并且许多预测的残基位于P450c17的活性位点内或附近。然而,由于酶活性需要酶与底物之间在小于1埃的距离内相互作用,并且建模无法预测大于1.5 - 2.0埃的原子位点,因此不可能设计出能赋予P450c17 21-羟化酶活性的突变体。目前可用的数据无法预测特定P450活性的结构和氨基酸序列要求。